Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

FDA approves pembrolizumab with chemotherapy for biliary tract cancer

FDA approves pembrolizumab with chemotherapy for biliary tract cancer

FDA approves toripalimab-tpzi for nasopharyngeal carcinoma

FDA approves toripalimab-tpzi for nasopharyngeal carcinoma

Metixene breakthrough: A new hope emerges for metastatic brain cancer patients

Metixene breakthrough: A new hope emerges for metastatic brain cancer patients

ESMO 2O23: Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50 percent

ESMO 2O23: Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50 percent

Researchers identify biology behind aggressive breast cancers in Black women

Researchers identify biology behind aggressive breast cancers in Black women

FDA approves ivosidenib for myelodysplastic syndromes

FDA approves ivosidenib for myelodysplastic syndromes

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chances

Breast cancer survivors: New training to treat 'chemo-brain'

Breast cancer survivors: New training to treat 'chemo-brain'

New technology could lead to quick, minimally invasive cancer diagnoses

New technology could lead to quick, minimally invasive cancer diagnoses

Viral reprogramming of cells increases risk of cancer in HIV patients

Viral reprogramming of cells increases risk of cancer in HIV patients

More from ecancer